Table 4.
Cannabinoid preferences of MED vs. MEDREC users.
| MED users | MEDREC users | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Light n=200 (38%) | Moderate n=197 (37%) | Heavy n=134 (25%) | X2 | p | Light n=107 (23%) | Moderate n=185 (40%) | Heavy n=166 (36%) | X2 | p | |
| Cannabis strain used | ||||||||||
| Indica | 66 (37.5%) | 53 (29.4%) | 42 (32.3%) | 3.92 | 0.417 | 24 (24.2%) | 40 (22.6%) | 47 (28.5%) | 3.16 | 0.531 |
| Sativa | 15 (8.5%) | 24 (13.3%) | 15 (12.3%) | 14 (14.1%) | 18 (10.2%) | 21 (12.7%) | ||||
| Hybrid | 95 (54.0%) | 103 (57.2%) | 72 (55.4%) | 61 (61.6%) | 119 (67.2%) | 97 (58.8%) | ||||
| Ratio preference (% yes) | 141 (70.5%) | 138 (70.1%) | 91 (67.9%) | 1.8 | 0.410 | 67 (62.6%) | 138 (74.6%) | 110 (66.3%) | 5.5 | 0.063 |
| Preferred THC:CBD ratio | 46.0 | <0.0001 | 37.5 | <0.0001 | ||||||
| High THC : low CBD | 14 (9.9%) | 24 (17.1%) | 13 (14.3%) | 16 (23.9%) | 29 (21.0%) | 33 (30.0)%) | ||||
| High THC : high CBD | 39 (27.7%) | 45 (32.6%) | 55 (60.4%) | 17 (25.4%) | 63 (45.7%) | 60 (54.5%) | ||||
| Low THC : high CBD | 66 (46.8%) | 49 (35.5%) | 17 (18.7%) | 27 (40.3%) | 31 (22.5%) | 8 (7.3%) | ||||
| Low THC : low CBD | 4 (2.8%) | 7 (5.1%) | 0 (0.0%) | 2 (3.0%) | 6 (4.3%) | 1 (0.9%) | ||||
| Only THC | 4 (2.8%) | 1 (0.7%) | 1 (1.1%) | 1 (1.5%) | 3 (2.2%) | 2 (1.8%) | ||||
| Only CBD | 9 (6.4%) | 3 (2.2%) | 1 (1.1%) | 1 (1.5%) | 2 (1.4%) | 0 (0.0%) | ||||
| Other | 5 (3.5%) | 9 (6.5%) | 4 (4.4%) | 3 (4.5%) | 4 (2.9%) | 6 (5.5%) | ||||
| Administration routes (% answered) | 186 (93%) | 194 (98.5%) | 130 (97.0%) | 104 (97.2%) | 183 (98.9%) | 164 (98.8%) | ||||
| Smoking | 79 (42.5%) | 111 (57.2%) | 97 (74.6%) | 31.8 | <0.0001 | 86 (82.7%) | 159 (86.9%) | 156 (95.1%) | 19.4 | 0.0007 |
| Rank 1 and 2 | 57 (30.6%) | 83 (42.8%) | 80 (61.5%) | 35.6 | <0.0001 | 64 (61.5%) | 139 (76.0%) | 136 (82.9%) | 8.6 | 0.01 |
| Vaporizing | 101 (54.3%) | 133 (68.6%) | 110 (84.6%) | 31.6 | <0.0001 | 83 (79.8%) | 145 (79.2%) | 143 (87.2%) | 4.7 | 0.32 |
| Rank 1 and 2 | 84 (45.2%) | 111 (57.2%) | 79 (60.8%) | 39.3 | <0.0001 | 65 (62.5%) | 111 (60.7%) | 107 (65.2%) | 0.36 | 0.83 |
| Edible | 116 (62.4%) | 121 (62.4%) | 92 (70.8%) | 2.7 | 0.256 | 82 (78.8%) | 140 (76.5%) | 131 (79.9%) | 0.61 | 0.739 |
| Rank 1 and 2 | 82 (44.1%) | 59 (30.4%) | 46 (35.4%) | 16.8 | 0.002 | 39 (37.5%) | 58 (31.7%) | 58 (35.4%) | 1.4 | 0.84 |
| Topical application | 98 (52.7%) | 98 (50.5%) | 66 (50.8%) | 0.1 | 0.932 | 46 (44.2%) | 88 (48.1%) | 88 (53.7%) | 2.4 | 0.298 |
| Rank 1 and 2 | 38 (20.4%) | 41 (21.1%) | 16 (12.3%) | 5.8 | 0.21 | 11 (10.6%) | 19 (10.4%) | 8 (4.9%) | 9.3 | 0.053 |
| Tincture | 115 (61.8%) | 117 (60.3%) | 79 (60.8%) | 0.0 | 0.979 | 57 (54.8%) | 89 (48.6%) | 82 (50.0%) | 1.0 | 0.594 |
| Rank 1 and 2 | 81 (43.5%) | 65 (33.5%) | 31 (23.8%) | 18.9 | 0.0008 | 24 (23.1%) | 31 (16.9%) | 8 (4.9%) | 22.7 | 0.0001 |
Table 4. Values represent frequency (n), percent (%) and mean ± standard deviation (SD) for categorical and continuous variables, respectively. Differences assessed via Chi-square test. Tests were two tailed, with significance set at p < 0.05. Significant p values are bold.